2018
DOI: 10.1016/s0016-5085(18)32697-0
|View full text |Cite
|
Sign up to set email alerts
|

Mo1646 - Ursodeoxycholic Acid (UDCA) for the Prevention of Cholelithiasis after Bariatric Surgery: A Systematic Review and Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Ursodeoxycholic acid (UDCA) is an active pharmaceutical ingredient (API) used in clinical therapy for the treatment of cholestatic diseases . It is a secondary bile acid that, as reported in several papers and reviews, shows several pharmacological effects . Particularly, UDCA dissolves cholesterol gallstones, acting as a surfactant .…”
Section: Introductionmentioning
confidence: 99%
“…Ursodeoxycholic acid (UDCA) is an active pharmaceutical ingredient (API) used in clinical therapy for the treatment of cholestatic diseases . It is a secondary bile acid that, as reported in several papers and reviews, shows several pharmacological effects . Particularly, UDCA dissolves cholesterol gallstones, acting as a surfactant .…”
Section: Introductionmentioning
confidence: 99%